Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-009478)

Filing Details

Accession Number:: 0001209191-11-009478
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-02-14 19:33:04
Reporting Period:: 2011-02-11

Filing Date:: 2011-02-14
Accepted Time:: 2011-02-14 19:33:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1316175	Anthera Pharmaceuticals Inc	ANTH	Pharmaceutical Preparations (2834)	201852016

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314902	Colin Hislop	C/O Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward CA 94545	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-02-11	3,894	$0.00	50,062	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	15,183	Indirect	By The Hislop-Burton Family Trust

Footnotes

The shares, issued upon conversion of Series A-1 Preferred Stock, were originally purchased by Biovest III, an entity in which Dr. Hislop was an investor and partner. The shares were received by Dr. Hislop in a pro rata distribution to the partners in Biovest III for no additional consideration.